Update On This Recall
&
A company wants to know the effects of a drug that is approved and reported in multiple studies. The drug's effects are available in the literature.
What is highest level of evidence to investigate this drug?
A-RCT
B-Systematic review of RCTs
C-Cohort studies
D-Pharmaceutical company something
Almakrami: B-Systematic review of RCTs , Because It Mentioned "Highest Level Of Evidence"
Alhomrani: BEST WAY To Evaluate [NEW] Drug Is RCT (Not SYSTEMIC Review RCT . You Can't Do Systemic Review For A NEW FRESH DRUG)
But Since The Recall Clearly Mentioned "HIGHEST LEVEL OF EVIDENCE" , Then Answer Is B-Systematic review of RCTs
Best Way / Most Appropriate ➔ RCT
HIGHEST LEVEL OF EVIDENCE ➔ Systemic Review RCT
September 5, 2026 174 1
